Introduction {#Sec1}
============

The electrochemical proton gradient across the inner mitochondrial or bacterial cytoplasmic membrane in aerobic organisms is maintained by a series of membrane-bound redox-driven proton pumps. The final electron acceptor, O~2~, binds to cytochrome *c* oxidase (Cyt*c*O) at a bimetallic heme *a*~3~-Cu~B~ catalytic site where it is reduced by four electrons to water (Fig. [1a](#Fig1){ref-type="fig"}). During turnover of Cyt*c*O, electrons are transferred one-by-one from a water-soluble or membrane-associated cyt. *c* consecutively to the primary electron acceptor, Cu~A~, the secondary acceptor heme *a* and the catalytic site. The Cyt*c*O links this electron transfer to proton pumping from the more negative (*N*) to the more positive (*P*) side of the membrane with an average stoichiometry of one pumped proton per electron transferred to the catalytic site. Thus, the overall reaction is:$$\documentclass[12pt]{minimal}
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                \begin{document}$$4{{\rm{e}}}_{{\rm{p}}}^{-}+8{{\rm{H}}}_{{\rm{N}}}^{+}+{{\rm{O}}}_{2}\to 2{{\rm{H}}}_{2}{\rm{O}}+4{{\rm{H}}}_{{\rm{p}}}^{+}$$\end{document}$$where the subscripts *P* and *N* refer to the two sides of the membrane. The free energy for reduction of O~2~ by cyt. *c* is \~2 eV, which is used to move 8 charges across the membrane; 4 protons that are pumped across the membrane and, 4 electrons and 4 protons that are transferred from opposite sides of the membrane resulting in a charge separation (summarized in^[@CR1]^).Figure 1Experimental system and the studied reaction. (**a**) Cyt*c*O accommodates four redox-active centers: Cu~A~, heme *a* and the catalytic site composed of heme *a*~3~ and Cu~B~, that upon reduction each bind one electron. The cyt. *c*-Cyt*c*O electrostatic complex accommodates in total five electrons in the reduced state. Two proton-uptake pathways, called D and K are indicated in the figure, but not discussed in the text. (**b**) Turnover of Cyt*c*O. One electron at a time is donated from cyt. *c* to Cyt*c*O. The initial state is the "relaxed" oxidized state. Consecutive addition of two electrons yields the two-electron reduced catalytic site which binds O~2~ to form the peroxy state P~M~. Reduction of P~M~ yields F, which is then reduced to form the "activated" oxidized state, O~H~. This state is then reduced by cyt. *c*. (**c**) Reaction studied in this work. The oxidized cyt. *c*-Cyt*c*O complex is reduced by 5 electrons. Upon initiation of the reaction (with a laser flash, not shown), O~2~ binds to the catalytic site and an electron is transferred from heme *a* to the catalytic site to form the peroxy state, P~R~. This step is followed in time by formation of the ferryl state, F, which occurs over the same time scale as electron equilibration among Cu~A~/cyt. *c* and heme *a*. Electron transfer from this equilibrium to the catalytic site leads to formation of state O~H~. Over a longer time scale of \~0.1 s an electron equilibrates between the Cyt*c*O molecules via the bound cyt. *c* to eventually yield oxidized Cyt*c*O. Note that proton-transfer reactions are not indicated in the Figure.

A number of distinct intermediate states have been identified and characterized during Cyt*c*O turnover (Fig. [1b](#Fig1){ref-type="fig"}). Consecutive transfer of two electrons to the oxidized Cyt*c*O (denoted **O**) yields formation of the one- (denoted **E**) and two- (denoted **R**) electron reduced catalytic site. When heme *a*~3~ and Cu~B~ are reduced, O~2~ binds to the heme iron after which the O-O bond is broken to form a ferryl state called "peroxy" for historical reasons (denoted **P**~**M**~). Transfer of an additional electron and a proton to **P**~**M**~, results in formation of the ferryl state, **F**. Further transfer of an electron and a proton to **F** yields the oxidized Cyt*c*O (**O**~**H**~, see below). The overall process has been reviewed in the past^[@CR1]--[@CR14]^ and it is summarized in Fig. [1b](#Fig1){ref-type="fig"}.

Early studies indicated that the free energy from O~2~ reduction is not released evenly in the four electron-transfer reactions, but the majority of this free energy was found to be liberated in the **P**~**M**~ → **F** and **F** → **O** reaction steps^[@CR15]^. Furthermore, elegant studies performed by Wikström suggested that proton pumping is coupled only to these two steps^[@CR16]^, which stimulated Wikström and colleagues to propose a detailed molecular model based on these findings^[@CR17]^. According to this model, two protons would be pumped in each of the reactions **P**~**M**~ → **F** and **F** → **O**, while no proton pumping would be observed upon reduction of the Cyt*c*O, i.e. **O** → **E** → **P**~**M**~. Later, a novel kinetic approach was used to obtain data^[@CR18]^ that resulted in re-evaluation of the model to yield a scenario where one proton is pumped in each of the four reaction steps that involve electron transfer to the catalytic site^[@CR19]^.

A key aspect of the new model was postulation of a "high-energy" metastable oxidized form of the Cyt*c*O that would presumably differ in structure from the oxidized "as isolated" (**O**) state. The state is denoted **O**~**H**~ and it is assumed to be formed as a product of the **F** → **O**~**H**~ reaction (below we denote by **O**~**H**~ the oxidized state that is formed after re-oxidation of the reduced Cyt*c*O independently of the properties of this state)^[@CR18]^. According to this scenario part of the free energy released in **P**~**M**~ → **F** and **F** → **O**~**H**~ would be conserved in the **O**~**H**~ state to be used during subsequent reduction of the Cyt*c*O, i.e. the reaction sequence **O**~**H**~ → **E** → **P**~**M**~ would be more exergonic than **O** → **E** → **P**~**M**~. The question arises: what is the difference between states **O** and **O**~**H**~?

Postulation of state **O**~**H**~ also found support in an experimental observation: when starting from the fully oxidized Cyt*c*O (**O**) the free energy associated with electron transfer from cyt. *c* to heme *a*~3~-Cu~B~, before O~2~ binds, is too small to drive proton translocation (see Kaila *et al*.^[@CR1]^). Consequently, one possible difference between the "as isolated" state **O** and state **O**~**H**~ could be that in the latter the midpoint potentials of heme *a*~3~ and Cu~B~ are higher than those in state **O**^[@CR19],[@CR20]^. Indeed, data from experimental^[@CR21]^ and theoretical^[@CR22]^ studies suggested that the midpoint potential of Cu~B~ is significantly elevated in state **O**~**H**~. Furthermore, Blomberg and Siegbahn found that the inherent midpoint potential of Cu~B~ is high during catalytic turnover, and that in the resting oxidized state a slow protonation process may cause a significant decrease of the proton-coupled reduction potential^[@CR23]^. As discussed in the paper by Belevich *et al*.^[@CR21]^, there are conflicting experimental data regarding possible differences in the Cu~B~ midpoint potentials between states **O** and **O**~**H**~. For example, Jancura *et al*.^[@CR24]^ did not observe any spectral or kinetic differences between the **O**~**H**~ and **O** forms of Cyt*c*O. Brand *et al*.^[@CR25]^ prepared Cyt*c*O in the **O** and **O**~**H**~ states, respectively, and then added one electron to each of the samples. They found that the extent of electron transfer from heme *a* to the catalytic site was relatively small and the same in both states, which indicated that the midpoint potential of Cu~B~ was not raised in state **O**~**H**~.

In the present study, we investigated the reaction of the reduced *Rhodobacter sphaeroides* Cyt*c*O with O~2~ in the absence and presence, respectively, of cyt. *c* at low ionic strength. In the latter case a cyt. *c*-Cyt*c*O electrostatic complex is formed (see Fig. [1a,c](#Fig1){ref-type="fig"}). This arrangement contrasts the earlier studies in that it resembles the *in vivo* situation where electrons are continuously fed into Cyt*c*O from the donor cyt. *c*. The cyt. *c*-Cyt*c*O complex accommodates five electrons. Upon binding of O~2~ four electrons are transferred to form H~2~O yielding the oxidized Cyt*c*O, presumably in state **O**~**H**~. Then the "fifth electron" can equilibrate among the five sites cyt. *c*, Cu~A~, heme *a*, heme *a*~3~ and Cu~B~^[@CR26]--[@CR28]^. We reasoned that if in state **O**~**H**~ the Cu~B~ midpoint potential would be elevated, this fifth electron would be transferred to Cu~B~. The data show that this was not the case and in \~90% of Cyt*c*Os the fifth electron was distributed among sites cyt. *c*, Cu~A~ and heme *a* with the largest fraction at heme *a*.

Results and Discussion {#Sec2}
======================

Spectral analysis {#Sec3}
-----------------

To determine whether or not binding of cyt. *c* to Cyt*c*O affects the spectral properties of the hemes, we recorded the reduced - oxidized difference spectra of each of the isolated proteins (cyt. *c* and Cyt*c*O) as well as of a mixture of the two at low ionic strength (i.e. the cyt. *c*-Cyt*c*O complex). As seen in Fig. [2](#Fig2){ref-type="fig"}, the sum of the cyt. *c* and Cyt*c*O difference spectra was essentially equal to that of the mixture, except for a small increase in the 550 nm absorbance peak upon forming the cyt. *c*-Cyt*c*O complex.Figure 2Absorbance difference spectra. A comparison of reduced minus oxidized difference spectra of the Cyt*c*O-cyt. *c* complex (black) and the sum of the reduced minus oxidized difference spectra of Cyt*c*O and cyt. *c* (red), respectively. Spectra of the oxidized states were recorded first and then the atmosphere in the cuvette was replaced for N~2~ after which the samples were reduced with ascorbate (2 mM) and hexaammineruthenium(II) chloride (1 μM). Reduction of the samples was followed in time by recording spectra over \~2 hours until no further changes were observed. The data to the right of the axis break have been multiplied by a factor of five. The concentrations of Cyt*c*O and cyt. *c* were \~3 μM and \~5 μM, respectively, in 50 mM HEPES (pH 7.5), 0.05% DDM and 100 µM EDTA.

Reaction of Cyt*c*O with O~2~ {#Sec4}
-----------------------------

The reduced Cyt*c*O carries four electron equivalents. Thus, upon reaction with O~2~ the Cyt*c*O becomes fully oxidized while O~2~ is reduced to H~2~O. The anaerobic samples were mixed with an O~2~-saturated solution in a stopped-flow apparatus. After \~200 ms the CO ligand was dissociated by means of a short laser flash, which initiates the reaction of the reduced Cyt*c*O with O~2~. In the absence of cyt. *c* (black traces in Fig. [3](#Fig3){ref-type="fig"}) the reaction exhibits a number of distinct kinetic steps, while populating states in which O~2~ is progressively reduced and protonated to eventually form H~2~O. The details of the reaction sequence have been described in the past^[@CR1],[@CR4],[@CR5],[@CR29],[@CR30]^ and it is outlined in Fig. [1c](#Fig1){ref-type="fig"}.Figure 3Kinetics of absorbance changes upon reaction with O~2~. The four-electron reduced Cyt*c*O (black traces) or the five-electron-reduced cyt. *c*-Cyt*c*O complex (red traces) was mixed with an O~2~-saturated buffer solution. About 200 ms after mixing with the O~2~-containing buffer, at time = 0, the CO-ligand was removed by a laser flash. The four-electron complex becomes oxidized over a time scale of 8 ms (left-hand side boxes). At 445 nm (**a**) the main contribution is from redox changes at hemes *a* and *a*~3~. At 605 nm (**b**) the main contribution is from redox changes at heme *a* (80%) and the remaining fraction originates from changes at heme *a*~3~. At 830 nm (**c**) the main contribution is from Cu~A~ where an increase in absorbance is associated with oxidation. At 550 nm (**d**) the main contribution is from redox changes at cyt. *c*. At 445 nm and 605 nm, the rapid change in absorbance at *t* = 0 is associated with CO dissociation. It is followed in time by a decrease in absorbance associated with binding of O~2~ (τ ≅ 10 μs), formation of the **P**~**R**~ state (τ ≅ 40 μs) and oxidation of the Cyt*c*O (τ ≅ 1.5 ms). The **P**~**R**~ → **F** reaction is not seen at these wavelengths. At 830 nm two components are seen with time constants of 200 µs (**P**~**R**~ → **F**) and 1.5 ms (**F** → **O**). Oxidation of cyt. *c* occurs over the same time scale. In the presence of cyt. *c* absorbance changes attributed to the Cyt*c*O (panels a--c) were smaller because the redox sites were re-reduced by cyt. *c* during the course of the reaction. Over a time scale of \~500 ms (right-hand side boxes) all redox sites become oxidized. The small increase in absorbance over this time scale in the absence of cyt. *c* is due to small fractional re-reduction of Cyt*c*O by ascorbate. Experimental conditions after mixing: 1.1 μM Cyt*c*O, 20 mM HEPES at pH 7.5, 0.05% DDM, 100 μM EDTA, 2 mM ascorbate, 1 μM hexa-ammine-ruthenium(II) chloride, 1 mM O~2~ at \~22 °C (black trace). The red traces are averages of three traces obtained under the following conditions: \[cyt. *c*\]/\[Cyt*c*O\] in μM (*i*) 2.1/1.6, (*ii*) 1.5/1.3, (*iii*) 1.7/1.3. The mixing ratio was 1:5 with an oxygen-saturated buffer solution (20 mM HEPES at pH 7.5). All traces have been scaled to 1 μM reacting Cyt*c*O based on the rapid change in absorbance at 445 nm at *t* = 0. A laser artifact at *t* = 0 has been truncated for clarity.

At 445 nm and 605 nm the main contribution to the absorbance changes is from both hemes *a* and *a*~3~. At 830 nm and 550 nm the main contribution is from Cu~A~ and cyt. *c*, respectively. The **A** → **P**~**R**~ and **F** → **O** reactions are seen as a decrease in absorbance with time constants of \~40 μs and \~1.5 ms (Fig. [3a,b](#Fig3){ref-type="fig"}), respectively, at both 445 nm and 605 nm. The **P**~**R**~ → **F** reaction is not seen at these wavelengths, but fractional oxidation of Cu~A~ that is linked in time to the **P**~**R**~ → **F** reaction^[@CR31]^ is seen at 830 nm where we observed an increase in absorbance with a time constant of \~200 μs (Fig. [3c](#Fig3){ref-type="fig"}). Also the remaining oxidation of Cu~A~, linked in time to the **F** → **O**~**H**~ reaction, is seen as a further increase in absorbance at 830 nm. We did not observe any absorbance changes at 550 nm in the absence of cyt. *c*, which shows that at this wavelength the contribution from redox changes of Cyt*c*O is negligible (Fig. [3d](#Fig3){ref-type="fig"}, black trace).

Over a longer time scale we observed a slight re-reduction of hemes *a* and *a*~3~, seen as a small increase in absorbance at 445 nm and 605 nm (see right-hand side boxes of panels a and b).

Reaction of the cyt. *c*-Cyt*c*O complex with O~2~ {#Sec5}
--------------------------------------------------

A mixture of cyt. *c* and Cyt*c*O, in a low-ionic strength solution (see Materials and Methods), was reduced and incubated under an atmosphere of CO. The cyt. *c* was added at a slight excess to Cyt*c*O (1.2--1.3 cyt. *c*/Cyt*c*O) to assure formation of the cyt. *c*-Cyt*c*O complex in the major fraction of the population (see below). We first discuss the absorbance changes over a time scale of 8 ms (black traces in Fig. [3](#Fig3){ref-type="fig"}). Over this time scale four electrons are delivered from Cyt*c*O to O~2~, as discussed above.

When cyt. *c* is bound to Cyt*c*O an electron is transferred from cyt. *c* to Cu~A~ upon the first, fractional oxidation of Cu~A~, i.e. during the **P**~**R**~ → **F** reaction (τ ≅ 200 μs), and then during the **F** → **O**~**H**~ reaction (τ ≅ 1.5 ms) while Cu~A~/heme *a* are oxidized further (red traces in Fig. [3](#Fig3){ref-type="fig"})^[@CR26]--[@CR28]^. These oxidation reactions are seen as a decrease in absorbance at 550 nm with time constants of \~200 μs and \~1.5 ms, respectively. All other absorbance changes over a time scale of 8 ms were diminished in the presence of cyt. *c*, reflecting re-reduction of the Cyt*c*O redox sites by cyt. *c* (compare the red and black traces in Fig. [3a--c](#Fig3){ref-type="fig"}).

The absorption coefficients of the redox sites at the measured wavelengths are listed in Table [1](#Tab1){ref-type="table"}. All data in Fig. [3](#Fig3){ref-type="fig"} were scaled to 1 μM reacting Cyt*c*O, based on the absorption coefficient for the CO-dissociation absorbance change at 445 nm. This normalization was only done to simplify comparison of the data at different wavelengths and it does not influence the analysis below.Table 1Reduced minus oxidized difference absorption coefficients (Δε) of the redox sites, except the first line where the Δε is given for CO binding to the reduced heme *a*~3~.Redox site or reactionΔε mM^−1^cm^−1^wavelength (nm)ReferenceCyt*c*O-CO-Cyt*c*O67445^[@CR33]^cyt. *c*21.1550^[@CR46]^Cu~A~2.3830^[@CR47]^1.6^[@CR34]^heme *a*~3~112445^[@CR33]^82.3444^[@CR32]^heme *a*57445^[@CR33]^66.4446^[@CR32]^heme *a*20.5605^[@CR33]^18.6^[@CR32]^heme *a*~3~4.8605^[@CR33]^4.6^[@CR32]^

Further oxidation of the cyt. *c*-Cyt*c*O complex after reaction with O~2~ {#Sec6}
--------------------------------------------------------------------------

In the five-electron cyt. *c*-Cyt*c*O system the single remaining electron after oxidation of the Cyt*c*O is not rapidly transferred to the excess oxygen (i.e. to a second O~2~) because O~2~ does not bind to the catalytic site when it is reduced by only one electron. Instead, oxidation of the hemes occurred over a longer time scale of \~500 ms, see right-hand side boxes in Fig. [3](#Fig3){ref-type="fig"}. This process may involve either (*i*) transfer of the electron to the optically silent Cu~B~, or (*ii*) electron exchange between the Cyt*c*O molecules, via cyt. *c*, eventually yielding a thermodynamically stable state. The oxidation state of the Cyt*c*O catalytic site in this stable state would depend on the number of electrons transferred to the specific enzyme molecule. The most likely scenario is that an electron is exchanged between two Cyt*c*Os such that one molecule becomes oxidized and the other forms state **P**~**M**~.

To discriminate between these two scenarios we reasoned that in case (*i*) the time constant of the slowest oxidation reaction would be independent of the Cyt*c*O concentration while in case (*ii*) this time constant would decrease upon dilution because the reaction involves electron exchange between Cyt*c*O molecules mediated via cyt. *c*. As seen in Fig. [4](#Fig4){ref-type="fig"}, the time constant of the slowest component increased from \~75 ms to \~300 ms upon increasing the dilution of the Cyt*c*O-cyt. *c* sample with the O~2~-containing buffer from 1:1 to 1:5. This observation indicates that the slowest component is due to electron exchange between Cyt*c*O molecules according to scenario (*ii*).Figure 4Kinetics of absorbance changes upon reaction with O~2~ upon dilution. The experiment is the same as that shown in Fig. [3](#Fig3){ref-type="fig"}, but the Cyt*c*O-containing sample was mixed 1:1 (black) or 1:5 (red) with the O~2~-containing buffer. Note the different absorbance scales in the left and right parts of the graph, respectively. The concentrations of Cyt*c*O and cyt. *c* were 5 µM and 7.5 µM, respectively.

At 550 nm we observed a decrease in absorbance in the time range 8-500 ms (see Fig. [3d](#Fig3){ref-type="fig"}) that was added on top of the oxidation of the fraction reduced cyt. *c* in the cyt. *c*-Cyt*c*O complex. This signal was observed because there was an excess of 1.2--1.3 cyt. *c* compared to Cyt*c*O. Over this longer time scale this excess cyt. *c* in solution, became fully oxidized.

For the Cu~A~ absorbance changes at 830 nm (Fig. [3c](#Fig3){ref-type="fig"}) the absorbance reached a higher level with than without cyt. *c* at 500 ms, which is discussed below.

Analysis of the data {#Sec7}
--------------------

We define the absorbance difference, at wavelength λ, after *x* ms and immediately after the flash, i.e. at time = 0^+^: Δ*A*^λ^(*x*) = *A*^λ^(*t* = *x* ms) - *A*^λ^(*t* = 0^+^). As already indicated above, in the absence of cyt. *c*, Δ*A*^λ^(8) reflects oxidation of the reduced Cyt*c*O. We note that a comparison of this absorbance change at e.g. 445 nm and 605 nm, and that associated with CO-dissociation typically deviates from the equivalent differences seen in static spectra (Table [1](#Tab1){ref-type="table"}). Therefore, we found that the most reliable approach to analyze the absorbance changes associated with oxidation of hemes *a* and *a*~3~ is to compare Δ*A*^445^(8) and Δ*A*^605^(8) with and without cyt. *c* added. This approach does not require the knowledge of absorption coefficients of hemes *a* and *a*~3~, only their relative contribution must be known. As seen in Table [1](#Tab1){ref-type="table"}, at 605 nm hemes *a* and *a*~3~ contribute with 80% and 20%^[@CR32],[@CR33]^, respectively. At 445 nm we used the relative contributions determined by Vanneste^[@CR33]^: 66% and 34% for hemes *a*~3~ and *a*, respectively. The relative contributions determined by Liao *et al*.^[@CR32]^ differed from these values, but the use of these values yields the same conclusions (see below).

The fractions hemes *a* and *a*~3~ (δ(*a*) and δ(*a*~3~), respectively) that become oxidized after 8 ms in the presence of cyt. *c* are determined from:$$\documentclass[12pt]{minimal}
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                \begin{document}$$\frac{{\rm{\Delta }}{A}_{+{\rm{cyt}}.c}^{445}(8)}{{\rm{\Delta }}{A}^{445}(8)}=0.34{\rm{\delta }}(a)+0.66\,{\rm{\delta }}({a}_{3})=0.75$$\end{document}$$$$\documentclass[12pt]{minimal}
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                \begin{document}$$\frac{{\rm{\Delta }}{A}_{+{\rm{cyt}}.c}^{605}(8)}{{\rm{\Delta }}{A}^{605}(8)}=0.80\delta (a)+0.20\delta ({a}_{3})=0.50$$\end{document}$$which yields δ(*a*) = 0.40 ± 0.04 and δ(*a*~3~) = 0.94 ± 0.06 (SD, 3 measurements). In other words, \~60% of heme *a*, but only \~6% of heme *a*~3~ become re-reduced when cyt. *c* is present. When using the relative contributions of hemes *a* and *a*~3~, respectively, based on the absorption coefficients determined by Liao *et al*.^[@CR32]^ (see Table [1](#Tab1){ref-type="table"}), the corresponding values would be δ(*a*) ≅ 0.5 and δ(*a*~3~) ≅ 1, i.e. \~50% re-reduced heme *a* and no heme *a*~3~ re-reduced.

Next, we calculate the fraction Cu~A~ that becomes re-reduced in the presence of cyt. *c* from the absorbance changes at 830 nm (Fig. [3c](#Fig3){ref-type="fig"}). At this wavelength oxidation of Cu~A~ leads to an increase in absorbance.

We compare the absorbance levels after 8 ms obtained in the absence and presence of cyt. *c*: $\documentclass[12pt]{minimal}
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                \begin{document}$$0.85\pm 0.08$$\end{document}$ (SD, three measurements), which yields \~15% re-reduced Cu~A~ when cyt. *c* is present.

We note that the absorbance levels at 830 nm after 500 ms in the presence and absence of cyt. *c* differ. This difference is most likely due to contribution of state **P**~**M**~, at 830 nm^[@CR34]^, formed at the catalytic site after electron exchange between the Cyt*c*Os in the presence of cyt. *c* (see explanation above).

The fraction oxidized cyt. *c* is calculated from the absorbance changes at 550 nm (Fig. [3d](#Fig3){ref-type="fig"}). We calculated the fraction from the ratio of absorbance changes at 500 ms (full oxidation of the cyt. *c* pool) and 8 ms, respectively, assuming that the fraction oxidized cyt. *c* over the time scale of 8 ms reflects cyt. *c* that was bound in complex with Cyt*c*O.

The fraction oxidized cyt. *c* after 8 ms, $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\frac{{\rm{\Delta }}{A}_{+{\rm{cyt}}.c}^{550}(8)}{{\rm{\Delta }}{A}_{+{\rm{cyt}}.c}^{550}(500)}$$\end{document}$ is 0.68. This number must be scaled for the molar excess cyt. *c* as compared to Cyt*c*O, which is 1.2 (in the experiment shown in Fig. [3d](#Fig3){ref-type="fig"}). Thus, assuming a 1:1 cyt. *c*-Cyt*c*O complex, the absorbance changes at 8 ms yield oxidation of 84 ± 7% (SD, 3 measurements) of the bound cyt. *c*. The occupancy of the cyt. *c*-binding site is not known, but because the degree of cyt. *c* oxidation is close to unity, the assumption of a 1:1 cyt. *c*:Cyt*c*O complex is at least approximately correct.

To test whether or not the presence of detergent could alter the midpoint potentials of Cyt*c*O in state **O**~**H**~, we also repeated the experiments with native membranes from *R. sphaeroides* (Fig. [5](#Fig5){ref-type="fig"}). Due to light scattering of the membrane fragment the signal-to-noise ratio in these measurements was much smaller than that seen with detergent-solubilized Cyt*c*O. Therefore, we had to exclude data at 830 nm where the absorbance changes associated with redox changes at Cu~A~ are very small (see Table [1](#Tab1){ref-type="table"}). We observed a smaller degree of cyt. *c* oxidation over \~8 ms, presumably because part of cyt. *c* binds to the membrane fragments, being inaccessible to Cyt*c*O. Nevertheless, we could estimate the degree of cyt. *c* oxidation and reduction of hemes *a* and *a*~3~. The fraction oxidized cyt. *c* per Cyt*c*O was \~0.4 (Fig. [5c](#Fig5){ref-type="fig"}), based on a comparison with the data in Fig. [3d](#Fig3){ref-type="fig"}. The fraction reduced hemes *a* and *a*~3~ was estimated using Eqs ([1](#Equ1){ref-type=""} and [2](#Equ2){ref-type=""}) above and the absorbance differences Δ*A*^445^(8) and Δ*A*^605^(8) in Fig. [5a,b](#Fig5){ref-type="fig"}. These data indicate that at 8 ms after initiation of the reaction, heme *a*~3~ is not reduced while heme *a* is essentially fully reduced, which is qualitatively consistent with the data obtained with Cyt*c*O in detergent solution.Figure 5Reaction of membrane fragments with O~2~. The experiment is the same as that shown in Fig. [3](#Fig3){ref-type="fig"}. Absorbance changes were monitored at 445 nm (**a**) 605 nm (**b**) and 550 nm (**c**) Experimental conditions after mixing: *R. sphaeroides* membranes (∼2 µM Cyt*c*O, calculated from the reduced minus oxidized difference spectrum) in 20 mM HEPES (pH 7.5), 100 µM EDTA and 1 mM O~2~ at ∼22 °C. The mixing ratio was 1:1 with an oxygen-saturated buffer (20 mM HEPES pH 7.5). The traces have been scaled to 1 µM reacting Cyt*c*O. A laser artifact at *t* = 0 has been truncated for clarity.

Interpretation of the data obtained with detergent-solubilized Cyt*c*O is summarized in the illustration in Fig. [6](#Fig6){ref-type="fig"}. We found that at the end of the initial oxidation of the Cyt*c*O, i.e. after 8 ms, the fraction reduced cyt. *c* is 0.16. In other words, we assume that 0.84 electrons reside among the four redox sites of Cyt*c*O. The reduction levels of hemes *a* and *a*~3~ were 0.60 and 0.06, respectively, while that of Cu~A~ was 0.15. These numbers are obtained from the measured absorbance changes. When adding these fractions reduced hemes *a* and *a*~3~ and Cu~A~ we obtain 0.81. Because 0.84 electrons reside at Cyt*c*O (based on the degree of oxidation of cyt. *c*), the fraction reduced Cu~B~ is 0.03. It should be noted that this number is not measured directly because Cu~B~ is optically silent. It is calculated based on the assumption that the cyt. *c*-Cyt*c*O complex comprises five redox-active centers and that each of these sites can harbor one electron.Figure 6Summary of the data. The redox state of the co-factors is indicated with color. The fraction color in the small circles reflects the degree of reduction of each redox site. The apparent redox potentials were estimated from the fractions reduced redox sites assuming a midpoint potential of 250 mV for Cu~A~. The numbers are based on the assumption that the cyt. *c*-Cyt*c*O complex accommodates five redox sites and that each site can accommodate one electron. No interactions between the redox sites are considered (see text).

On the basis of this distribution of the fifth electron among the five redox sites cyt. *c*, Cu~A~, heme *a*, heme *a*~3~ and Cu~B~, and assuming a midpoint potential of 250 mV for Cu~A~^[@CR35]^, we estimate the apparent redox potentials of the redox sites in Cyt*c*O in state **O**~**H**~ (Fig. [6](#Fig6){ref-type="fig"}). We refer to "apparent" redox potentials because the analysis reflects only the distribution of a single electron after 500 ms in the five-electron system (among five sites). Because interactions between the redox sites are not considered (see^[@CR35],[@CR36]^), the values differ from those obtained in redox titrations, which typically yield a higher midpoint potential for the catalytic site heme (here heme *a*~3~) than for the intermediate electron acceptor (here heme *a*)^[@CR35],[@CR36]^, although in many bacterial oxidases the difference between the midpoint potentials is reversed^[@CR37]^. Furthermore, because a single electron equilibrates among the five redox sites, the situation differs from a redox titration^[@CR38]^. The purpose of the exercise to calculate the apparent redox potentials is not to provide the values, only to indicate that the apparent redox potential of Cu~B~ is not higher than that of any other site after reaction of the Cyt*c*O with O~2~. The main conclusion is that the fifth electron is not found at the catalytic site.

Belevich and colleagues^[@CR21]^ concluded that upon injection of a single electron to state **O**~**H**~ less than 2% heme *a* was reduced and that the midpoint potential of Cu~B~ was raised to a value at least 100 mV higher than that of heme *a*. This contrasts the 60% reduced heme *a* observed here and we did not find an increased midpoint potential of Cu~B~. One difference between our study and that of Belevich *et al*. is the different experimental approach; we used cyt. *c* as the electron donor while Belevich *et al*. used a Ru-complex excited by light. Even though the binding geometry and overall charge of these two electron donors differ, the differences are not likely to explain the discrepancy in the Cu~B~ midpoint potentials because of the significant distance between the site where the electron donor binds and Cu~B~. Belevich and colleagues^[@CR21]^ discussed the discrepancy between their results and those obtained in other laboratories prior to the present study, and suggested that they may originate from exposure of the Cyt*c*O to detergent or removal of phospholipids during enzyme isolation. As discussed above, we did not find any additional reduction of the catalytic site with Cyt*c*O in its native lipid environment.

In earlier studies using an identical experimental approach to that used here^[@CR39],[@CR40]^ we did observe differences between Cyt*c*O that was reconstituted in liposomes and in detergent. However, these differences were mainly observed for the kinetics of reactions that are associated with proton uptake from solution, presumably due to interaction of lipids with groups near the entry point of the Cyt*c*O proton pathways^[@CR40]^.

The experimental approach used here reflects the conditions in the native system where cyt. *c* is the electron donor. Yet, one may argue that in our experiments the electron from cyt. *c* was transferred over a time scale that is shorter than that of **O**~**H**~ formation, i.e., an alternative explanation is that the state formed is not **O**~**H**~. State **O** is defined as the "relaxed form" of the oxidized Cyt*c*O, reached after long time without turnover, i.e. not the transient state visited in the experiments described here. Consequently, if we assume that **O**~**H**~ is not formed here, we would have to assume a third oxidized state. Furthermore, we would have to postulate that formation of **O**~**H**~ requires a delay between oxidation and re-reduction of the Cyt*c*O. However, the concentration of O~2~ in mammalian tissues is only a few μM^[@CR41]^, which suggests that at steady state heme *a*/Cu~A~ would be at least partly reduced, resembling the states visited in the current study, as also indicated in^[@CR42]^. We also note that in the experiments described by Belevich and colleagues^[@CR21]^ the delay between oxidation and injection of the fifth electron was \~5 ms and over this time scale we did not observe any additional heme oxidation.

Summary {#Sec8}
=======

An activated form of the oxidized Cyt*c*O, **O**~**H**~, was postulated. The difference between states **O** and **O**~**H**~ was suggested to be an elevated midpoint potential of Cu~B~ in the latter. In the present study, we used an alternative experimental technique to approach the problem and found that in the **O**~**H**~ state the electron resides mainly at heme *a* and Cu~A~. In other words the Cu~B~ midpoint potential was not elevated in **O**~**H**~. A similar behavior was observed in native membrane, which excludes the possibility that the behavior is due to removal of lipids from the protein.

Materials and Methods {#Sec9}
=====================

Preparation of *R. sphaeroides* CytcO {#Sec10}
-------------------------------------

The *R. sphaeroides* bacteria were grown aerobically in the dark at 30 °C in a Sistrom medium. After harvesting, the cells were re-suspended in 50 mM Tris-buffer, pH 8.0 (0.2 g/ml) and stirred for one hour at 4 °C in the presence of DNase I (0.05 mg/ml final concentration). The suspension was subsequently passed twice through a continuous-flow cell disruptor (Constant Systems LTD) operating at 170 MPa. Unbroken bacteria and cell debris were removed from the suspension by low-speed ultra-centrifuging (7800 g for 15 min at 4 °C) followed by high-speed ultra-centrifugation (138 000 g for 90 minutes at 4 °C) to collect the membrane fraction. The membrane pellet was re-suspended (homogenized) in 50 mM Tris-buffer.

For purification of the Cyt*c*O the membrane fraction of the cells was solubilized in 1.5% *n*-dodecyl β -D-maltoside (DDM). The histidine-tagged Cyt*c*O was purified using Ni^2+^-NTA affinity chromatography as described previously^[@CR43],[@CR44]^.

Measurement of the oxidation kinetics {#Sec11}
-------------------------------------

For studies of Cyt*c*O in the native membrane environment the *R. sphaeroides* membranes were diluted to \~5 μM Cyt*c*O in 20 mM HEPES (pH 7.5) and 100 μM EDTA.

For studies of the purified Cyt*c*O, the buffer-solution of the enzyme was exchanged for 20 mM HEPES (pH 7.5), 0.05% DDM and 100 μM EDTA using a gel filtration column (PD-10, GE Healthcare), resulting in a final Cyt*c*O concentration of \~10 μM. The same method was used to prepare the cyt. *c*-Cyt*c*O complex where equine heart cyt. *c* (Sigma-Aldrich) was added to the Cyt*c*O prior application to the PD-10 column. For the *R*. *sphaeroides* membrane fraction, the equine heart cyt. *c* was added directly to the sample.

The cyt. *c*-Cyt*c*O ratio was 1.2--1.3 (see text and figure legends). The sample was transferred to a locally modified Thunberg cuvette after which air in the cuvette was exchanged for N~2~ using a vacuum line. The sample was reduced upon anaerobic addition of ascorbate (2 mM) and the redox mediator hexa-ammine-ruthenium(II) chloride (1 μM). After full reduction, the N~2~ atmosphere in the cuvette was replaced by carbon monoxide, which binds to the reduced heme *a*~3~. The redox state of the enzyme as well as formation of the Cyt*c*O-CO complex were verified spectrophotometrically.

The Cyt*c*O-CO complex (with or without cyt. *c*) was mixed rapidly with an oxygen-saturated buffer (20 mM HEPES (pH 7.5), 0.05% DDM, 0.1 mM EDTA) at a Cyt*c*O:O~2~-saturated solution ratio of 1:5) in a flow-flash apparatus (Applied Photophysics). The CO ligand was photo-dissociated from heme *a*~3~, about 200 ms after mixing, by means of a 10-ns laser flash (Quantel Brilliant B, Nd-YAG, 532 nm), enabling oxygen to bind to heme *a*~3~. The subsequent reaction of the reduced Cyt*c*O with oxygen was monitored as absorbance changes over time at different single wavelengths^[@CR45]^.
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